ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Covid-19 Reinfection in a Kidney Transplant Patient

Z. Saeed Zafar, D. Malhotra

Nephrology, Yale School of Medicine, New Haven, CT

Meeting: 2021 American Transplant Congress

Abstract number: 762

Keywords: Antibodies, Immunosuppression, Infection, Kidney

Topic: Clinical Science » Infectious Disease » All Infections (Excluding Kidney & Viral Hepatitis)

Session Information

Session Name: All Infections (Excluding Kidney & Viral Hepatitis)

Session Type: Poster Abstract

Session Date & Time: None. Available on demand.

Location: Virtual

*Purpose: Several cases have demonstrated positive SARS-CoV-2 PCR testing in patients who were initially shown to have cleared the infection. These reinfections may represent new strains of SARS-CoV-2 that can have significant clinical implications in the transplant population and affect public health initiatives aimed at controlling this pandemic. The purpose of this case is to highlight the presentation of COVID-19 reinfection in a kidney transplant recipient.

*Methods: We present a 66-year-old male patient with a history of ESRD due to lithium toxicity, status post deceased donor kidney transplant, maintained on Belatacept, prednisone and mycophenolate mofetil. He was first diagnosed with COVID-19 in March 2020 after presenting with cough, fever and hypoxia. Chest x-ray revealed bilateral infiltrates. Treatment included atazanavir, hydroxychloroquine and tocilizumab. Mycophenolate was withheld for the duration of his treatment. Despite resolution of all symptoms, nasopharyngeal PCR testing remained positive for SARS-CoV-2 even on discharge. He subsequently cleared his infection and tested negative twice, 3 months apart. He was later found to have AKI and a biopsy showed Banff 2A Acute Cellular Rejection which was treated with steroids and thymoglobulin. He was readmitted in November with fatigue and shortness of breath and tested positive again for SARS-CoV-2 by nasopharyngeal swab PCR. There was no hypoxia and chest x-ray did not show any infiltrates. Prerenal azotemia resolved with IV hydration. Serological studies showed presence of SARS-CoV2 IgG antibodies. Mycophenolate was again held. There was concern that this could be prolonged intermittent shedding from his previous infection. However genetic sequencing from samples of his first and current infection were compared and revealed a different strain consistent with a new infection. He recovered and was discharged.

*Results: COVID-19 reinfection in the transplant population is of significant interest as these patients may be susceptible to prolonged recovery. Several points of interest can be derived from this case. Firstly, the clinical significance of different viral strains and its effect on vaccination efforts may provide significant public health information. Second, the utility and importance of SARS-COV2 antibody testing may provide insight into the course of reinfection and degree of protection conferred by antibodies thereby providing guidance about the appropriate management of immunosuppression. Our patient had SARS-CoV-2 antibodies and his mild course allowed us to re-institute his immunosuppression early. Lastly, the potential for reinfection may necessitate continued testing and protective measures beyond vaccination efforts.

*Conclusions: To the best of our knowledge this is the first reported case of COVID-19 reinfection in a kidney transplant recipient with a different viral strain confirmed by genetic sequencing.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Zafar ZSaeed, Malhotra D. Covid-19 Reinfection in a Kidney Transplant Patient [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/covid-19-reinfection-in-a-kidney-transplant-patient/. Accessed May 11, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences